CAD Phenotypes Found for Tailored Prevention 03/28/26
Welcome to Cardiology Today â Recorded March 28, 2026. This episode summarizes 5 key cardiology studies on topics like heart failure and prognosis. Key takeaway: CAD Phenotypes Found for Tailored Prevention.
Article Links:
Article 1: Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study. (Heart (British Cardiac Society))
Article 2: Identifying clinical phenotype clusters in patients with coronary artery disease. (Heart (British Cardiac Society))
Article 3: Optimizing NT-proBNP Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry. (ESC heart failure)
Article 4: Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin Inhibitors. (ESC heart failure)
Article 5: Sex- and Phenotype-Specific Prognostic Implications of Body Mass Index in Acute Heart Failure. (ESC heart failure)
Full episode page: https://podcast.explainheart.com/podcast/cad-phenotypes-found-for-tailored-prevention-03-28-26/
đ Featured Articles
Article 1: Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40691042
Summary: A national cohort study of 852914 adult patients in England and Wales found that one-year all-cause mortality following acute myocardial infarction declined between 2005 and 2019. Researchers analyzed this 15-year dataset to quantify the contributions of clinical, treatment, and demographic factors to these changes. The findings provide crucial data for informing clinical strategies and health policy.
Article 2: Identifying clinical phenotype clusters in patients with coronary artery disease.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40451277
Summary: This study found that clinical phenotype clusters exist in patients with coronary artery disease. Researchers used unsupervised machine learning through latent class analysis to identify these clusters. The study assessed the relationship of these identified phenotypes with the risk of recurrent cardiovascular events. This work addresses the need for specific considerations beyond current one-size-fits-all guideline recommendations for cardiovascular event prevention.
Article 3: Optimizing NT-proBNP Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41894572
Summary: This study provided evidence-based guidance on selecting optimal N-terminal pro-B-type natriuretic peptide cut-offs for randomized controlled trials in heart failure. Researchers utilized data from the Swedish Heart Failure Registry, applying N-terminal pro-B-type natriuretic peptide cut-offs ranging from 200 to 5000 picograms per milliliter, which were derived from prior randomized controlled trials. The study calculated one-year incidence proportions to optimize the balance between event enrichment and screening failure across various heart failure subgroups. This optimizes patient selection for clinical trials, improving efficiency and relevance.
Article 4: Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin Inhibitors.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41885188
Summary: This study compared the characteristics and therapeutic response of patients with obstructive hypertrophic cardiomyopathy who only showed treatment-qualifying left ventricular outflow tract obstruction during exercise echocardiography, versus those who met eligibility at rest. Researchers assessed the therapeutic response to cardiac myosin inhibitors, specifically mavacamten, in these patient groups. The findings clarify the clinical profile and treatment response of patients who require exercise imaging to establish eligibility for these inhibitors. This work helps identify appropriate candidates for mavacamten therapy.
Article 5: Sex- and Phenotype-Specific Prognostic Implications of Body Mass Index in Acute Heart Failure.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41885184
Summary: This study found that the prognostic implications of body mass index in patients with acute heart failure differed according to heart failure phenotype and sex. Researchers analyzed 5271 patients hospitalized for acute heart failure from the Korean Heart Failure three Registry. Body mass index was categorized into low, normal, and high groups using Asia-Pacific criteria. The primary outcome was a composite of two-year all-cause mortality or heart transplantation, showing varying risks across subgroups.
đ Transcript
Today’s date is March 28, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study. A national cohort study of 852914 adult patients in England and Wales found that one-year all-cause mortality following acute myocardial infarction declined between 2005 and 2019. Researchers analyzed this 15-year dataset to quantify the contributions of clinical, treatment, and demographic factors to these changes. The findings provide crucial data for informing clinical strategies and health policy.
Article number two. Identifying clinical phenotype clusters in patients with coronary artery disease. This study found that clinical phenotype clusters exist in patients with coronary artery disease. Researchers used unsupervised machine learning through latent class analysis to identify these clusters. The study assessed the relationship of these identified phenotypes with the risk of recurrent cardiovascular events. This work addresses the need for specific considerations beyond current one-size-fits-all guideline recommendations for cardiovascular event prevention.
Article number three. Optimizing N-terminal pro-B-type natriuretic peptide Inclusion Cut-offs for Randomized Clinical Trials in Heart Failure: Data from the Swedish Heart Failure Registry. This study provided evidence-based guidance on selecting optimal N-terminal pro-B-type natriuretic peptide cut-offs for randomized controlled trials in heart failure. Researchers utilized data from the Swedish Heart Failure Registry, applying N-terminal pro-B-type natriuretic peptide cut-offs ranging from 200 to 5000 picograms per milliliter, which were derived from prior randomized controlled trials. The study calculated one-year incidence proportions to optimize the balance between event enrichment and screening failure across various heart failure subgroups. This optimizes patient selection for clinical trials, improving efficiency and relevance.
Article number four. Role of Provocation and Exercise Imaging for the Identification of Candidates for Cardiac Myosin Inhibitors. This study compared the characteristics and therapeutic response of patients with obstructive hypertrophic cardiomyopathy who only showed treatment-qualifying left ventricular outflow tract obstruction during exercise echocardiography, versus those who met eligibility at rest. Researchers assessed the therapeutic response to cardiac myosin inhibitors, specifically mavacamten, in these patient groups. The findings clarify the clinical profile and treatment response of patients who require exercise imaging to establish eligibility for these inhibitors. This work helps identify appropriate candidates for mavacamten therapy.
Article number five. Sex- and Phenotype-Specific Prognostic Implications of Body Mass Index in Acute Heart Failure. This study found that the prognostic implications of body mass index in patients with acute heart failure differed according to heart failure phenotype and sex. Researchers analyzed 5271 patients hospitalized for acute heart failure from the Korean Heart Failure three Registry. Body mass index was categorized into low, normal, and high groups using Asia-Pacific criteria. The primary outcome was a composite of two-year all-cause mortality or heart transplantation, showing varying risks across subgroups.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
heart failure, prognosis, coronary artery disease, machine learning, randomized controlled trials, one-year mortality, body mass index, Swedish Heart Failure Registry, inclusion criteria, acute heart failure, heart failure phenotype, prevention, sex differences, national registry, N-terminal pro-B-type natriuretic peptide, cardiac myosin inhibitors, acute myocardial infarction, mavacamten, phenotype clusters, exercise echocardiography, obstructive hypertrophic cardiomyopathy, clinical strategies, recurrent cardiovascular events, left ventricular outflow tract obstruction, health policy.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow